Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases.

MLA

Ebadi, Manuchair, et al. “Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases.” Current Drug Targets, vol. 7, no. 11, Nov. 2006, pp. 1513–29. EBSCOhost, https://doi.org/10.2174/1389450110607011513.

APA

Ebadi, M., Brown-Borg, H., Ren, J., Sharma, S., Shavali, S., El ReFaey, H., & Carlson, E. C. (2006). Therapeutic efficacy of selegiline in neurodegenerative disorders and neurological diseases. Current Drug Targets, 7(11), 1513–1529. https://doi.org/10.2174/1389450110607011513

Chicago

Ebadi, Manuchair, Holly Brown-Borg, Jun Ren, Sushil Sharma, Shaik Shavali, Hesham El ReFaey, and Edward C Carlson. 2006. “Therapeutic Efficacy of Selegiline in Neurodegenerative Disorders and Neurological Diseases.” Current Drug Targets 7 (11): 1513–29. doi:10.2174/1389450110607011513.